The need to manage the risk of thromboembolism in COVID-19 patients
Authors:
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 72 (3) , 799-804
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysisClinica Chimica Acta, 2020
- Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaJournal of Thrombosis and Haemostasis, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulationJournal of Thrombosis and Haemostasis, 2019
- Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patientsJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2019
- New findings on venous thrombogenesisHamostaseologie, 2017
- New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide surveyBMJ Open, 2017
- Physiology and pathophysiology of the plasminogen system in the kidneyPflügers Archiv - European Journal of Physiology, 2017
- A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction ScoreJournal of Thrombosis and Haemostasis, 2010
- Plasminogen and plasmin activity in patients with coronary artery diseaseJournal of Thrombosis and Haemostasis, 2006